Hannover Clinical Trial Center GmbH   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Hannover Germany (2005)

Organization Overview

First Clinical Trial
2008
NCT00803309
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Hannover Clinical Trial Center | Hannover Clinical Trial Center GmbH | Hannover Clinical Trial Center HCTC GmbH | Hannover Medical School, Department of Pneumology

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 3)

Anemia, Iron-Deficiency (Phase 3)

Astrocytoma (Phase 3)

Borderline Personality Disorder (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Cholangiocarcinoma (Phase 2)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Nephropathies (Phase 3)

Diabetic Retinopathy (Phase 3)

Fibrosis (Phase 4)

Glioblastoma (Phase 3)

Glioma (Phase 3)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis C (Phase 4)

Hepatitis C, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hepatitis D (Phase 2)

Hepatitis D, Chronic (Phase 2)

Hypertension (Phase 3)

Hypertension, Pulmonary (Phase 3)

Infections (Phase 4)

Kidney Diseases (Phase 3)

Leukemia (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 3)

Liver Cirrhosis (Phase 4)

Lung Neoplasms (Phase 3)

Neoplasms, Neuroepithelial (Phase 3)

Personality Disorders (Phase 2)

Retinal Diseases (Phase 3)

Schizophrenia (Phase 3)

Virus Diseases (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 16
  • # of Trial APIs: 31